Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05676294 · ClinicalTrials.gov registry record · Phase 2
The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory Surgery
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 384
- Enrollment target
NCT05676294 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 384 participants.
The verdict
NCT05676294, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 384 participants
- Enrollment target
Study Summary
The primary objective of this phase 2 randomized controlled trial is to determine whether the pre-operative administration of olanzapine (5 mg PO) improves quality of recovery (assessed by the Quality of Recovery-40 (QoR-40) survey) on postoperative day 1 in patients having ambulatory surgery with general anesthesia. The secondary objectives of this study are to determine whether there are differences in quality of recovery on postoperative day 2, presence of post-discharge nausea, presence of severe post-discharge nausea, recovery room length of stay and opioid consumption in patients who receive the study drug versus placebo.
Interventions
- DRUG Placebo
- DRUG Olanzapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 384 participants |
| Start Date | 2023-06-26 |
| Est. Completion | 2025-12-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05676294
The ClinicalTrials.gov registry entry for NCT05676294 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 384 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05676294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05676294 about?
NCT05676294 is a clinical study titled "The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory Surgery". The primary objective of this phase 2 randomized controlled trial is to determine whether the pre-operative administration of olanzapine (5 mg PO) improves quality of recovery (assessed by the Quality of Recovery-40 (QoR-40) survey) on postoperative day 1 in patients having ambulatory surgery with g...
What is the current status of trial NCT05676294?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 384 participants. The study started on 2023-06-26. Estimated completion is 2025-12-06.
What interventions are being tested in trial NCT05676294?
The interventions under investigation include: Placebo (DRUG), Olanzapine (DRUG).
Who is sponsoring clinical trial NCT05676294?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.